Cadrenal Therapeutics Announces Exercise of Warrants for $4.7 Million Gross Proceeds ...Middle East

PR Newswire - News
Cadrenal Therapeutics Announces Exercise of Warrants for $4.7 Million Gross Proceeds
PONTE VEDRA, Fla., Nov. 1, 2024 /PRNewswire/ -- Cadrenal Therapeutics, Inc., ("Cadrenal" or the "Company") (Nasdaq: CVKD), a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible anticoagulant (blood thinner) for certain rare medical conditions, today...

Hence then, the article about cadrenal therapeutics announces exercise of warrants for 4 7 million gross proceeds was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Cadrenal Therapeutics Announces Exercise of Warrants for $4.7 Million Gross Proceeds )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News